2026年是"十五五"开局之年。坚持创新驱动，加紧培育壮大新动能，是2026年经济工作要抓好的重 点任务。其中，创新科技金融服务是中央经济工作会议明确的重点工作之一。 "投贷联动""投保联动" 探索扩大试点范围 2025年在做好科技金融服务方面做了较多探索，国家创业投资引导基金在近日启动，形成了万亿资 金规模，将把种子期、初创期、早中期企业作为投资重点，用耐心资本陪伴企业"长跑"；国家金融监督 管理总局扩大金融资产投资公司（AIC）股权投资试点至全国18城，引导银行系资本"投早、投小、投 硬科技"；多地试点知识产权质押或者推动知识产权证券化，将分散专利打包成标准化金融产品进入资 本市场。 "创新科技金融服务的核心是打通'科技—产业—金融'的良性循环，让金融资源精准匹配硬科技企 业全生命周期的发展需求。"在受访专家看来，2026年创新科技金融服务将推出多项举措：一是健全知 识产权质押融资机制，推进知识产权质押贷款"前补偿"试点，让轻资产科创企业获得更多融资支持；二 是扩大"投贷联动""投保联动"试点范围，银行贷款与股权投资相结合，实现风险共担、收益共享；三是 培育耐心资本，推动AIC股权投资和科技创新债券发展， ...

证券研究报告 | 2025年12月28日 ETF 周报 上周 A500ETF 净申购近 500 亿元，本周将新发行 2 只科创板 芯片 ETF 核心观点 金融工程周报 ETF 业绩表现 上周（2025 年 12 月 22 日至 2025 年 12 月 26 日，下同）股票型 ETF 周度收益率中位数为 2.75%。宽基 ETF 中，中证 500ETF 涨跌幅中位 数为 4.04%，收益最高。按板块划分，周期 ETF 涨跌幅中位数为 5.37%， 收益最高。按主题进行分类，新能车 ETF 涨跌幅中位数为 7.17%，收益 最高。 ETF 规模变动及净申赎 上周股票型 ETF 净申购 356.34 亿元，总体规模增加 1322.02 亿元。在 宽基 ETF 中，上周 A500ETF 净申购最多，为 493.22 亿元；按板块来 看，消费 ETF 净赎回最少，为 5.80 亿元；按热点主题来看，医药 ETF 净申购最多，为 4.08 亿元。 ETF 基准指数估值情况 在宽基 ETF 中，创业板类 ETF 的估值分位数相对较低；按板块来看， 消费、大金融 ETF 的估值分位数相对温和；按照细分主题来看，酒、新 能车 ...

从基金公司层面来看，有多家公司推出多只产品同步发行。其中易方达基金以7只产品的发行量位居首 位，鹏华基金紧随其后，发行6只产品。国泰基金、招商基金、平安基金分别发行5只和4只产品，形成 了头部公司引领、中小型公司积极跟进的竞争格局。 从时间分布来看，基金发行呈现显著的年末集中特征。数据显示，74只基金（占比66.7%）于12月份启 动募集，92只基金（占比82.9%）计划在12月完成募集，反映出基金公司普遍把握年终窗口，积极展开 年末发行收官战并布局来年。 在产品布局上，被动指数型基金数量占比近30%，覆盖科创板、人工智能、港股通、高端制造等市场热 点板块。例如，易方达推出科创板芯片ETF，国泰基金布局港股通互联网ETF，鹏华基金则集中发行了 卫星产业、通用航空等主题ETF。 今年公募基金发行数据整体向好，随着年末临近，仍有多家基金公司冲刺年末发行。 Wind最新数据显示，目前市场上共有111只公募基金处于正在发行状态，涵盖偏股混合型、被动指数 型、FOF、债券型等多类产品，形成了年内少有的集中发行热潮。另外，11月以来新发基金募集规模不 低，全市场新成立公募基金共计191只，合计募集资金规模达到1473.1 ...

【首批科创创业人工智能ETF等16只硬科技基金今日获批 即将启动募集】智通财经11月21日电，投资者布 局硬科技又有新工具，硬科技行业也再得资金加持。智通财经记者获悉，16只硬科技产品今日迅速获批， 包括易方达、华泰柏瑞、工银瑞信、永赢、景顺长城、摩根、鹏华、天弘等11家基金公司拿到入场券。16 只产品包括首批7只科创创业人工智能ETF、3只科创板芯片ETF、4只科创板芯片设计主题ETF，以及2只科 技主题主动权益类基金。本次获批产品中，部分产品于11月21日当天受理，当天便得到批文，有基金公司 人士称，这传递出监管部门支持战略性新兴产业的积极信号。业内预计，16只产品将于近期启动募集，吸 引一批专注于科技领域投资的新增资金入市。（智通财经记者 闫军） 人工智能 | 半导体芯片 | TMT行业观察 长按右侧二维码阅读原文 准确 快速 权威 专业 CL S 为速度和交易而生 机构和私募都在使用 于11月21日当天受理,当天便得到批文,有基金 公司人士称,这传递出监管部门支持战略性新兴产 业的积极信号。业内预计,16只产品将于近期启动 募集,吸引一批专注于科技领域投资的新增资金入 市。 (财联社记者 闫军) ...

Group 1 - The core viewpoint of the articles highlights a surge in the issuance of technology-focused ETFs, particularly those targeting the artificial intelligence (AI) sector, indicating a strong interest from public fund companies in this area [1][3][4] - Seven public fund companies have launched the first batch of "Double Innovation Artificial Intelligence ETFs," with one company ending its fundraising early due to reaching the 1 billion yuan limit [1][2][3] - The ETFs are designed to track the CSI Innovation and Entrepreneurship Artificial Intelligence Index, which includes 50 leading companies focused on AI technology development and its commercial applications across various sectors [3][4] Group 2 - A total of 19 new ETFs targeting the AI sector, including robotics and semiconductors, have been reported to the China Securities Regulatory Commission (CSRC) within a week, reflecting the growing trend in technology investments [2][3] - The influx of funds into these technology ETFs is expected to bring over 30 billion yuan in new capital to the AI and technology sectors if all funds reach their maximum fundraising targets [3] - Industry experts attribute the rapid growth in technology ETF offerings to supportive government policies, strong market performance, and a competitive landscape among fund companies [4][5] Group 3 - Investment managers express a strong belief in the long-term potential of AI, alongside other sectors such as semiconductors, biotechnology, and clean energy, viewing AI as a "golden track" for long-term investments [5][6] - Key investment opportunities within AI are identified as the computing power and algorithm sectors, with a particular focus on storage-related opportunities in the computing power segment [6] - Companies that can integrate AI into their business models to innovate products or services are also seen as valuable investment prospects [6]

Core Viewpoint - The regulatory body is implementing a counter-cyclical adjustment mechanism for fund product approvals to better protect investor interests, emphasizing a cautious approach towards new equity fund approvals amid high valuation benchmarks [1][2][7]. Fund Approval and Market Conditions - Regulatory scrutiny on new equity funds has increased, requiring that the performance benchmark index's rolling valuation over the last five years be below the 90th percentile and the last three months below the 80th percentile [2][3]. - Despite a bullish A-share market, fund companies are exercising restraint in launching new equity funds, with many setting initial fundraising caps at 2 billion to 3 billion yuan [1][4]. Fund Product Trends - Recent approvals have favored funds in sectors with relatively low valuations, such as healthcare, food, and consumer electronics, indicating a strategic focus on value [3][4]. - The approval of 16 hard technology products in mid-November reflects the regulatory body's timely response to market fluctuations, showcasing the effectiveness of the counter-cyclical adjustment mechanism [3][7]. Scale Management and Investor Experience - Fund companies are actively controlling the scale of new products, with many setting fundraising limits between 2 billion and 3 billion yuan, contrasting with the past trend of large-scale fund launches [4][5]. - Over 100 equity funds have announced restrictions on large subscriptions, with a focus on protecting existing investors and maintaining stable fund operations [5][6]. Regulatory Changes and Industry Transformation - The regulatory framework is shifting from a focus on scale to quality, with new performance evaluation metrics emphasizing long-term investment returns and investor experience [6][7]. - The implementation of counter-cyclical adjustment mechanisms is expected to enhance the capital market's resource allocation and support long-term investment strategies [7].

Core Viewpoint - The regulatory body is implementing a counter-cyclical adjustment mechanism for fund product approvals to better protect investor interests, emphasizing a cautious approach towards new equity fund approvals amid high valuation benchmarks [1][2][6]. Group 1: Regulatory Actions - The approval process for new equity funds has become more stringent, with requirements for performance benchmarks to be below the 90th percentile for the last five years and the 80th percentile for the last three months [2][3]. - The regulatory framework encourages fund companies to focus on quality over size, promoting a rational and restrained approach during market highs and increasing counter-cyclical investments during market lows [2][6]. Group 2: Market Trends - Despite a bullish A-share market, fund companies are limiting the scale of new equity fund launches, with many setting initial fundraising caps at 2 billion to 3 billion yuan [1][4]. - A significant portion of newly established equity funds this year has set fundraising limits, with 57% of these caps below 3 billion yuan [5]. Group 3: Fund Management Practices - Fund companies are actively controlling the scale of new products and limiting large subscriptions for existing high-performing funds to protect investor interests and maintain stable fund operations [5][6]. - The focus is on aligning fund size with strategy capacity to avoid increased transaction costs and ensure a fair investment experience for all investors [5]. Group 4: Long-term Investment Ecosystem - The deepening implementation of the counter-cyclical adjustment mechanism is shifting the public fund industry from a focus on scale to one on quality, which is expected to attract more long-term capital and enhance investor satisfaction [7]. - Regulatory measures are designed to create a balanced approval rhythm that avoids excessive capital inflow into popular sectors while supporting key areas like hard technology during market corrections [7].

Core Viewpoint - The approval of fund products is initiating a counter-cyclical adjustment mechanism to better protect investor interests under the guidance of the "Action Plan for Promoting High-Quality Development of Public Funds" [1][2] Group 1: Regulatory Adjustments - Regulatory scrutiny on new equity fund approvals has increased, particularly for those with high performance benchmarks, requiring recent five-year rolling valuations to be below the 90th percentile and three-month valuations below the 80th percentile [2][3] - The approval process is being optimized to maintain a rational and restrained approach during market highs while increasing counter-cyclical investments during market lows [2][6] Group 2: Fund Issuance and Management - Fund companies are exhibiting restraint in issuing new equity funds, with many setting initial fundraising caps at 2 billion to 3 billion yuan, contrasting with the past trend of launching large-scale funds [5][6] - Over 50% of the 1,045 new equity funds established this year have set fundraising limits, with 57% of these limits below 3 billion yuan [5] Group 3: Market Response and Strategy - The approval of new funds has focused on sectors with relatively low valuations, such as healthcare and consumer electronics, especially during periods of market volatility [3][4] - The industry is shifting from a focus on scale to quality, aiming to attract more long-term capital and enhance investor satisfaction through better fund management practices [7] Group 4: Performance Evaluation and Investor Experience - The regulatory framework has been restructured to emphasize fund performance over size and revenue, with new metrics introduced to evaluate fund managers based on investor service and experience [6][7] - The implementation of counter-cyclical adjustment mechanisms is expected to improve the overall investment experience for investors and stabilize the capital market [7]

Core Viewpoint - The approval of fund products is undergoing a counter-cyclical adjustment mechanism to better protect investor interests, with a more cautious approach towards new equity fund approvals due to high valuation benchmarks [2][4][11]. Group 1: Regulatory Adjustments - Regulatory scrutiny has increased for new equity funds, requiring that the performance benchmark index's rolling valuation over the last five years be below the historical 90th percentile and the last three months below the 80th percentile [5][6]. - The approval process has been optimized, with a focus on sectors with relatively low valuations, such as healthcare, food, and consumer electronics [5][6]. Group 2: Market Behavior and Fund Management - Despite a bullish A-share market, fund companies are exercising restraint in new equity fund launches, with many setting initial fundraising caps at 2 billion to 3 billion yuan [2][9]. - A significant number of new equity funds launched this year have set fundraising limits, with 57% of these limits below 3 billion yuan [9]. Group 3: Investor Experience and Fund Performance - The industry is shifting from a focus on scale to quality, aiming to enhance investor experience and long-term returns [11]. - Fund companies are implementing measures such as subscription limits and dynamic allocation to ensure fair investment experiences for all investors [9][11]. Group 4: Long-term Investment Ecosystem - The deepening implementation of the counter-cyclical adjustment mechanism is expected to attract more long-term capital into the public fund industry, enhancing investor satisfaction [11]. - The regulatory framework is evolving to emphasize long-term performance and investor returns, moving away from traditional metrics like scale and revenue [9][11].

Core Viewpoint - The launch of the first batch of seven China Securities Innovation and Entrepreneurship Artificial Intelligence ETFs is expected to inject over 30 billion yuan into the A-share hard technology sector, reflecting strong market interest in AI-related investments [1][3]. Group 1: ETF Launch and Market Impact - The first batch of seven China Securities Innovation and Entrepreneurship Artificial Intelligence ETFs was approved on November 21 and will be available for subscription starting November 28, with varying fundraising periods from three days to two weeks [1]. - These ETFs are expected to bring in over 30 billion yuan in new funds, with some products already nearing their fundraising limits on the first day of sale [1][3]. - The ETFs will be listed on both the Shanghai and Shenzhen stock exchanges, contributing to the liquidity and trading activity in the AI sector [4]. Group 2: Characteristics of the Dual Innovation AI ETF - The ETFs track the China Securities Innovation and Entrepreneurship Artificial Intelligence Index, which includes 50 companies involved in AI across the Science and Technology Innovation Board and the Growth Enterprise Market [2]. - The index's unique selection criteria and comprehensive coverage of the AI industry chain, including foundational resources, technology, and applications, differentiate it from other AI ETFs [5]. Group 3: Performance and Market Trends - The China Securities Innovation and Entrepreneurship Artificial Intelligence Index has significantly outperformed other AI indices this year, with a year-to-date increase of 85.06% compared to lower gains from other indices [6]. - The rapid approval of various technology-themed ETFs indicates a growing trend among fund companies to focus on hard technology sectors, with multiple applications submitted for ETFs in robotics, semiconductors, and innovative drugs [8][9]. Group 4: Long-term Outlook for the Technology Sector - Despite recent volatility in the A-share technology sector due to concerns over an AI bubble, institutions remain optimistic about the long-term investment opportunities in the technology space, particularly in AI and semiconductor sectors [12]. - The ongoing development of AI infrastructure and expanding application scenarios are expected to provide substantial growth potential for the industry [12].